Letter to the Editor

Area of Science:

• Genetics
• Personalized Medicine
• Bioethics

Background:

• Direct-to-consumer genetic testing (DTC-GT) has become increasingly accessible.
• Concerns exist regarding the interpretation and utility of DTC-GT results.
• The balance between benefits and questions surrounding DTC-GT requires examination.

Purpose of the Study:

• To critically evaluate the benefits and drawbacks of direct-to-consumer genetic testing.
• To address the growing number of questions arising from DTC-GT in personalized medicine.
• To stimulate discussion on the responsible implementation of genetic testing.

Main Methods:

• Literature review and critical analysis of existing studies on DTC-GT.
• Examination of ethical, legal, and social implications (ELSI) of DTC-GT.
• Discussion of the clinical utility and validity of DTC-GT information.

Main Results:

• DTC-GT often provides information with limited clinical actionability.
• The interpretation of genetic risk information can be complex and anxiety-provoking.
• Regulatory oversight and genetic counseling support for DTC-GT are often insufficient.

Conclusions:

• The current benefits of DTC-GT appear to be outweighed by the numerous unanswered questions.
• Enhanced genetic literacy and counseling are crucial for individuals undergoing DTC-GT.
• Further research and regulatory frameworks are necessary to ensure the responsible use of DTC-GT in healthcare.